Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
In our March issue, we examine the impact of COVID-19 on pharma, from the use of digital platforms for communication and training to the operational challenges of producing glass vials for vaccines. In Business, we also discuss the long-lasting influence of Brexit on pharma within the UK and beyond its shores. Meanwhile, our cover feature provides a snapshot of the progress being made in neuroscience R&D. Finally, we sit down with Jason Lacombe, CEO of Veratrak, who argues the cases for the uptake of blockchain technologies.